Suppr超能文献

MR 引导的非自适应 SBRT 治疗周围型肺部肿瘤中的肺保护。

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors.

机构信息

Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.

Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada.

出版信息

Biomed Phys Eng Express. 2024 Jun 20;10(4). doi: 10.1088/2057-1976/ad567d.

Abstract

We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality.Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities.PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R) for both modalities, indicating that Rmay serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R< 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met.The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; Rwas found to be an effective predictor for achievable lung metrics across modalities. Rcan assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

摘要

我们的目标是

(1)量化使用先进运动管理的非自适应磁共振引导立体定向体放射治疗(MRgSBRT)治疗周边型肺癌的肺保护益处,与常规 X 射线引导 SBRT(ConvSBRT)相比;(2)建立一个实用的决策指导指标,帮助临床医生选择合适的治疗方式。对 11 例在 MR 引导直线加速器(MR 直线加速器)上进行屏气门控 MRgSBRT 的周边型肺癌患者进行了研究。使用基于四维计算机断层扫描(4DCT)的内部靶区(ITV)进行了回顾性计划制定,以模拟 ConvSBRT,并与原始 MRgSBRT 计划进行了比较。分析的指标包括计划靶区(PTV)覆盖、各种肺指标和广义等效均匀剂量(gEUD)。推导出一种用于辅助未来患者在不同治疗方式之间进行分类的可实现肺指标的剂量预测因子。PTV 覆盖率高(中位数 V100%>98%),两种方式相似。MRgSBRT 的 V20(中位数 3.2%比 4.2%)、平均肺剂量(中位数 3.3Gy 比 3.8Gy)和 gEUD 明显较低。屏气门控 MRgSBRT 使 PTV 体积平均减少 47%,肺体积平均增加 19%。两种方式的肺指标与 PTV 与肺体积比(R)之间存在很强的相关性,表明 R 可以作为一种无需预计划的良好预测因子,用于预测可实现的肺指标。建议使用 ConvSBRT 时,R<0.035 可实现 V20<10%。如果无法达到阈值,则应考虑使用 MRgSBRT。对周边型肺肿瘤使用 MRgSBRT 的肺保护益处进行了量化;发现 R 是跨模式实现可实现肺指标的有效预测因子。R 可以帮助临床医生在无需繁琐预计划的情况下选择合适的治疗方式,这对繁忙的诊所具有重要的实际意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验